Relating To Insurer Prior Authorization.
SB832 would require health insurers regulated under Hawaii state law to align their prior authorization practices with Medicare-style standards for comparable services. The bill sets specific turnaround times for decisions—24 hours for urgent requests and three calendar days for non-urgent requests—and provides that a request is deemed approved if the insurer misses the deadline. It also limits documentation demands to be no more burdensome than Medicare’s, requires decisions to rely on nationally recognized evidence-based guidelines and Medicare medical-necessity standards, and makes prior authorizations valid for the full treatment course or 90 days, whichever is longer.
The bill further restricts insurers from retroactively denying payment for services that were previously authorized, except in cases of fraud, intentional misrepresentation, or failure to comply with policy terms stated at the time of authorization. It also creates oversight and enforcement mechanisms: the insurance commissioner would conduct annual audits, investigate complaints, receive quarterly insurer reports on authorization volume and response times, and make those reports public. Violations could lead to corrective action plans, public disclosure, and, for repeated or serious noncompliance, suspension or revocation of state licensure. Patients and providers would also be able to appeal denials directly to the commissioner for a binding decision within 30 days.
SB832 would amend Hawaii Revised Statutes chapter 431 by adding a new section governing prior authorization for state-regulated health insurers, including HMOs, PPOs, EPOs, and indemnity insurers. It would impose new procedural deadlines, documentation limits, reporting obligations, appeal rights, and enforcement authority on the insurance commissioner. The bill would not apply to ERISA-governed plans, Medicare Advantage plans, or other federally administered programs, so its reach is limited to state-regulated coverage. If enacted, it would materially change insurer utilization-management practices and likely reduce the ability of insurers to delay or deny care through prior authorization.
The bill text reflects a strongly pro-patient and pro-provider policy approach, emphasizing delays in care, administrative burden, and the need to streamline access to treatment. Although there are no committee transcripts or recorded votes in the provided materials, the framing of the measure suggests support for reforming prior authorization as a healthcare access issue. The overall tone is consumer-protective and reform-oriented, with the legislature presenting the bill as an effort to improve timeliness, consistency, and transparency in coverage decisions.
The main likely point of contention is the bill’s restriction on insurer discretion, especially the automatic approval provision if deadlines are missed and the limits on retroactive denials. Insurers may view the mandated Medicare alignment, short response times, public reporting, and potential licensure penalties as overly rigid or administratively burdensome. Another likely issue is the bill’s reliance on Medicare standards as the benchmark for commercial coverage, which could be criticized as not always fitting private-plan populations or benefit designs. Supporters, by contrast, would likely emphasize patient access, reduced paperwork, and accountability for delayed or inconsistent authorization decisions.